Lower Saxony is investing 20 million euros in startups for life sciences!

Lower Saxony is investing 20 million euros in startups for life sciences!

In Lower Saxony, a lot is happening in the area of ​​life sciences! With generous funding of a total of 20 million euros, the “Goe Future” project is launched, which is intended to boost the startup landscape in the Hanover-Göttingen-Braunschweig city triangle. The initiative aims to double the number of start -ups in this sector in the coming years. According to NDR consists of 10 million euros in private capital and a grant in the same amount of the bund. This is intended to strengthen the life sciences as a key technology in the region.

Goe Future plans to increase the number of startups in life sciences over 100 in the next five years. This includes research directions in medicine and biology that play a major role in the health system. The initiative has set itself the ambitious goal of consolidating Lower Saxony's position as a leading turntable for scientific innovations in Europe, reports Idw .

partnerships and university support

An important part of Goe Future are the many partnerships between universities and companies. The network is broadly positioned with 13 universities and research institutions as well as 14 companies. The universities in Göttingen and Hanover, the Hanover Medical School and well-known research institutes such as the Max Planck and the Fraunhofer Institute are all involved. Around 90,000 students are addressed by these collaborations, including about 20,000 in the life sciences, according to the information from Life Science Valley .

The initiative goes beyond simple funding and offers a “one-stop shop” to support founders who are accompanied by the idea to product development. Prof. Dr. Elisabeth Zeisberg, who coordinates the application process, emphasizes the need to look after startups without gaps.

innovations and local startups

The large number of innovative startups that are already based in Lower Saxony is particularly exciting. Projects such as Allogenetics GmbH that develop innovative methods for the immunological invisibility of donor organs, or Avocet Bio GmbH that researches antiviral therapies using Crispr/Cas13 to combat RNA viruses, show the great potential of the region. Further notes of startups are:

• Cardior Pharmaceutical GmbH : Developed therapies against heart diseases.
• Digity GmbH : produces individual finger orthoses and exoskeletons for rehabilitation.
• Repairon GmbH : works on artificial heart fabric from stem cells.

Thanks to the commitment that Goe Future shows, the networking of science and business in Lower Saxony is raised to a new level. By greater emphasis on innovation cycles and the support of life sciences, not only jobs could be created here, but also international standards.

With all of these factors, Lower Saxony could soon be known not only for its traditional industries, but also establish itself as a hotspot for innovative startups in the field of life sciences!